Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$57.89 - $64.73 $3.76 Million - $4.21 Million
65,000 Added 35.14%
250,000 $14.5 Million
Q2 2023

Aug 09, 2023

BUY
$63.71 - $70.74 $637,100 - $707,400
10,000 Added 5.71%
185,000 $11.8 Million
Q1 2023

May 11, 2023

BUY
$65.71 - $74.53 $328,549 - $372,650
5,000 Added 2.94%
175,000 $12.1 Million
Q3 2022

Nov 10, 2022

SELL
$0.13 - $76.84 $1,430 - $845,240
-11,000 Reduced 6.08%
170,000 $12.1 Million
Q2 2022

Aug 09, 2022

BUY
$72.62 - $79.98 $435,720 - $479,880
6,000 Added 3.43%
181,000 $13.9 Million
Q1 2022

May 10, 2022

SELL
$61.48 - $73.72 $922,200 - $1.11 Million
-15,000 Reduced 7.89%
175,000 $12.8 Million
Q4 2021

Feb 11, 2022

BUY
$53.63 - $62.52 $1.61 Million - $1.88 Million
30,000 Added 18.75%
190,000 $11.8 Million
Q3 2021

Nov 12, 2021

BUY
$59.17 - $69.31 $1.48 Million - $1.73 Million
25,000 Added 18.52%
160,000 $9.47 Million
Q2 2021

Aug 12, 2021

SELL
$61.91 - $67.42 $619,100 - $674,200
-10,000 Reduced 6.9%
135,000 $9.02 Million
Q1 2021

May 14, 2021

BUY
$59.34 - $66.74 $1.48 Million - $1.67 Million
25,000 Added 20.83%
145,000 $9.15 Million
Q4 2020

Feb 12, 2021

SELL
$57.74 - $65.43 $288,700 - $327,150
-5,000 Reduced 4.0%
120,000 $7.44 Million
Q2 2020

Aug 13, 2020

SELL
$54.82 - $64.09 $4.11 Million - $4.81 Million
-75,000 Reduced 37.5%
125,000 $7.35 Million
Q1 2020

May 12, 2020

BUY
$46.4 - $67.43 $4.18 Million - $6.07 Million
90,000 Added 81.82%
200,000 $11.1 Million
Q4 2019

Feb 13, 2020

SELL
$49.21 - $64.19 $2.71 Million - $3.53 Million
-55,000 Reduced 33.33%
110,000 $7.06 Million
Q3 2019

Nov 06, 2019

BUY
$42.77 - $50.71 $2.35 Million - $2.79 Million
55,000 Added 50.0%
165,000 $8.37 Million
Q2 2019

Aug 13, 2019

BUY
$44.62 - $49.34 $4.91 Million - $5.43 Million
110,000 New
110,000 $4.99 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Cna Financial Corp Portfolio

Follow Cna Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cna Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Cna Financial Corp with notifications on news.